Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
Clinical trial NCT04947189 · RECRUITING
Trial details
- NCT number
- NCT04947189
- Sponsor
- St Vincent's Hospital, Sydney
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2026-07-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.